Rocaglamide is primarily studied for its potential applications in cancer treatment due to its ability to inhibit the growth of cancer cells. It works by targeting specific proteins involved in cell survival and proliferation, making it a promising candidate for developing anti-cancer therapies. Additionally, it has shown effectiveness in suppressing inflammatory responses, which could be beneficial in treating inflammatory diseases. Research is ongoing to explore its full therapeutic potential and optimize its use in medical applications.